A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Clinical trial NCT06287918 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06287918
- Sponsor
- 3H (Suzhou) Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-03-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.